Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Celldex Therapeutics buy melinda

Celldex Therapeutics

Start price

€36.75

/ 50%

Target price

25.09.17

Performance (%)

End price

€41.34

Summary

This prediction ended on with a price of €41.34. The prediction had a final performance of . melinda has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y	3y
Celldex Therapeutics
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by melinda for this prediction

In the thread Celldex Therapeutics diskutieren

Prediction Buy

Perf. (%)

Target price 41.250

Change

Ends at

Firmenprofil

Celldex Therapeutics, Inc. engagiert in der Forschung, Entwicklung und Herstellung von Biopharmazeutika. Das Portfolio umfasst therapeutische Antikörper, Antikörper - Wirkstoff - Konjugate, Impfstoffe und Immunmodulatoren. Kandidaten mit Geschäfts Medikamenten gehören Glembatumumab vedotin, Varlilumab

0

Prediction Buy

Perf. (%)

Target price 41.250

Change

Ends at

(Zielkurs erreicht)

0

Stopped prediction by melinda for Celldex Therapeutics

Celldex Therapeutics

Start price

Target price

Perf. (%)

€5.30

30.10.19

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€5.01

22.01.19

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€31.52

19.03.18

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€33.15

25.09.17

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€65.08

07.10.16

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€154.08

13.10.14

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€176.42

13.12.13

50%

Celldex Therapeutics

Start price

Target price

Perf. (%)

€44.55

04.04.11

50%